Trial intelligence / Profile preview

Xi Feng Zhi Tong Granules for Migraine (Phase III)

CTR20140321Phase 3Active

Sponsor
Guangxi Qiangshou Pharmaceutical Group
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Xifeng Zhitong in migraine, sponsored by Guangxi Qiangshou Pharmaceutical Group. Started Oct 2014; status: active.

02

Drugs

Xifeng Zhitong
03

Conditions

migraine

Beyond the preview

Go deeper on CTR20140321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call